1. Market Research
  2. > Pharmaceutical
  3. > Drug and Medication Market Trends
  4. > Drug and Medication Analysis & Statistics, June 2015 (p2)

Drug and Medication Analysis & Statistics, June 2015 (p2)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

All regions

31-60 of about 7 300 reports

Purchase Reports From Reputable Market Research Publishers

2015 Clinical Chemistry and Immunodiagnostic Testing in US Hospitals, Commercial Laboratories and Point-of-Care/POC Locations

2015 Clinical Chemistry and Immunodiagnostic Testing in US Hospitals, Commercial Laboratories and Point-of-Care/POC Locations

  • $ 7 500
  • Industry report
  • June 2015
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7,500. “2015 Clinical Chemistry and Immunodiagnostics Testing in US Hospitals, Commercial Laboratories and Point-of-Care/POC ...

  • Industries : Drug and Medication
  • Countries : United States
Type 2 Diabetes Mellitus: KOL Insight

Type 2 Diabetes Mellitus: KOL Insight

  • $ 7 495
  • Industry report
  • July 2015
  • by Firstword Pharma

The market for Type 2 Diabetes therapies is extremely crowded. Several classes, including oral and injectable therapies, are all vying for market share. Differentiation remains a critical challenge. ...

  • Industries : General Medicine and Specialty Medicine, Drug and Medication
  • Countries : United States
Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation

Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation

  • $ 6 995
  • Industry report
  • June 2015
  • by GBI Research

Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation Summary Pancreatic cancer is the 12th most common cancer globally, and the fourth most fatal, with a mortality ...

  • Industries : General Medicine and Specialty Medicine, Pathology, Pharmaceutical, Healthcare
  • Countries : Japan
Insulin Markets in Western Europe to 2019 - Market Size, Development, and Forecasts

Insulin Markets in Western Europe to 2019 - Market Size, Development, and Forecasts

  • $ 6 504
  • Industry report
  • August 2015
  • by Global Research & Data Services Oy

The industry report package Insulin Markets in Western Europe to 2019 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook ...

  • Industries : Pathology, Drug and Medication, Pharmaceutical
  • Countries : Europe
Penicillin and Streptomycin Markets in Western Europe to 2019 - Market Size, Development, and Forecasts

Penicillin and Streptomycin Markets in Western Europe to 2019 - Market Size, Development, and Forecasts

  • $ 6 504
  • Industry report
  • August 2015
  • by Global Research & Data Services Oy

The industry report package Penicillin and Streptomycin Markets in Western Europe to 2019 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, ...

  • Industries : Drug and Medication
  • Countries : Europe
2015-2019 New Frontiers in the Point-of-Care/POC Clinical Chemistry and Immunodiagnostic Testing Market: Business Challenges, Emerging Technologies, Competitive Landscape

2015-2019 New Frontiers in the Point-of-Care/POC Clinical Chemistry and Immunodiagnostic Testing Market: Business Challenges, Emerging Technologies, Competitive Landscape

  • $ 5 500
  • Industry report
  • August 2015
  • by Venture Planning Group

“2015-2019 New Frontiers in Point-of-Care/POC Clinical Chemistry and Immunodiagnostic Testing: Business Challenges, Emerging Technologies, Competitive Landscape” is VPGMarketResearch’s new report, ...

  • Industries : Drug and Medication
  • Countries : United States
2015-2019 Decentralized/POC Clinical Chemistry and Immunodiagnostic Testing: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers--Supplier Shares, Country

2015-2019 Decentralized/POC Clinical Chemistry and Immunodiagnostic Testing: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers--Supplier Shares, Country

  • $ 5 500
  • Industry report
  • June 2015
  • by Venture Planning Group

“2015-2019 Decentralized/POC Clinical Chemistry and Immunodiagnostic Testing” is VPGMarketResearch’s new report, which provides comprehensive analysis of the POC clinical chemistry markets, including ...

  • Industries : Drug and Medication
  • Countries : United States
2015 New Frontiers in Point-of-Care/POC Clinical Chemistry and Immunodiagnostic Testing: Business Challenges, Emerging Technologies, Competitive Landscape

2015 New Frontiers in Point-of-Care/POC Clinical Chemistry and Immunodiagnostic Testing: Business Challenges, Emerging Technologies, Competitive Landscape

  • $ 5 500
  • Industry report
  • June 2015
  • by Venture Planning Group

“2015 New Frontiers in Point-of-Care/POC Clinical Chemistry and Immunodiagnostic Testing: Business Challenges, Emerging Technologies, Competitive Landscape” is VPGMarketResearch’s new report, which ...

  • Industries : Drug and Medication
  • Countries : United States
Type 2 Diabetes Mellitus Therapeutics in Major Developed Markets to 2021 - Strong Pipeline and Expanding Treatment Population to Encourage Robust Growth

Type 2 Diabetes Mellitus Therapeutics in Major Developed Markets to 2021 - Strong Pipeline and Expanding Treatment Population to Encourage Robust Growth

  • $ 4 995
  • Industry report
  • July 2015
  • by GBI Research

Type 2 Diabetes Mellitus Therapeutics in Major Developed Markets to 2021 - Strong Pipeline and Expanding Treatment Population to Encourage Robust Growth Summary Type 2 Diabetes Mellitus (T2DM) is a metabolic ...

  • Industries : Pharmaceutical, Therapy
  • Countries : World
Multiple Myeloma Therapeutics in Major Developed Markets to 2021 - Growth Driven by Rising Prevalence, Continued Success of Revlimid and Emerging Supplementary Treatments

Multiple Myeloma Therapeutics in Major Developed Markets to 2021 - Growth Driven by Rising Prevalence, Continued Success of Revlimid and Emerging Supplementary Treatments

  • $ 4 995
  • Industry report
  • July 2015
  • by GBI Research

Multiple Myeloma Therapeutics in Major Developed Markets to 2021 - Growth Driven by Rising Prevalence, Continued Success of Revlimid and Emerging Supplementary Treatments Summary Multiple Myeloma (MM) ...

  • Industries : Pharmaceutical, Therapy
  • Countries : World
Anti-hypertensive Therapeutics in Asia-Pacific Markets to 2021 - Increasing Prevalence of Hypertension Drives Market Growth despite Weak Pipeline

Anti-hypertensive Therapeutics in Asia-Pacific Markets to 2021 - Increasing Prevalence of Hypertension Drives Market Growth despite Weak Pipeline

  • $ 4 995
  • Industry report
  • July 2015
  • by GBI Research

Anti-hypertensive Therapeutics in Asia-Pacific Markets to 2021 - Increasing Prevalence of Hypertension Drives Market Growth despite Weak Pipeline Summary Hypertension is a chronic medical condition characterized ...

  • Industries : Pharmaceutical, Therapy, Pathology
  • Countries : World, Asia
2015-2019 Future Horizons and Growth Strategies in the Japanese Clinical Chemistry and Immunodiagnostics Market: Supplier Shares and Country Forecasts

2015-2019 Future Horizons and Growth Strategies in the Japanese Clinical Chemistry and Immunodiagnostics Market: Supplier Shares and Country Forecasts

  • $ 4 900
  • Industry report
  • August 2015
  • by Venture Planning Group

Complete report $7,600.  DataPack (test volumes, sales forecasts, supplier shares) $4,900. “2015-2019 Future Horizons and Growth Strategies in the Japanese Clinical Chemistry and Immunodiagnostics ...

  • Industries : Drug and Medication
  • Countries : Japan
2015-2019 New Frontiers in Japanese Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape

2015-2019 New Frontiers in Japanese Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape

  • $ 4 900
  • Industry report
  • August 2015
  • by Venture Planning Group

Complete report $7,600.  DataPack (test volumes, sales forecasts, supplier shares) $4,900. “2015-2019 New Frontiers in Japanese Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, ...

  • Industries : Drug and Medication
  • Countries : Japan
2015-2019 Japan Clinical Chemistry and Immunodiagnostics Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

2015-2019 Japan Clinical Chemistry and Immunodiagnostics Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

  • $ 4 900
  • Industry report
  • July 2015
  • by Venture Planning Group

Complete report $7,600.  DataPack (test volumes, sales forecasts, supplier shares) $4,900. “2015-2019 Japan Clinical Chemistry and Immunodiagnostics Market” is a new strategic analysis of major business ...

  • Industries : Drug and Medication
  • Countries : Japan
2015-2019 Japan Immunodiagnostics Market: Emerging Opportunities for Instrument and Reagent Suppliers--Competitive Strategies, Supplier Shares, Volume and Sales Segment Forecasts for 100 Tests

2015-2019 Japan Immunodiagnostics Market: Emerging Opportunities for Instrument and Reagent Suppliers--Competitive Strategies, Supplier Shares, Volume and Sales Segment Forecasts for 100 Tests

  • $ 4 900
  • Industry report
  • July 2015
  • by Venture Planning Group

Complete report $7,600.  DataPack (test volumes, sales forecasts, supplier shares) $4,900. “2015-2019 Japan Immunodiagnostics Market” is a new strategic analysis of major business opportunities emerging ...

  • Industries : Drug and Medication
  • Countries : Japan
2015-2019 Japanese Clinical Chemistry and Immunodiagnostic Markets: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies

2015-2019 Japanese Clinical Chemistry and Immunodiagnostic Markets: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies

  • $ 4 900
  • Industry report
  • June 2015
  • by Venture Planning Group

Complete report $7,600.  DataPack (test volumes, sales forecasts, supplier shares) $4,900. “2015-2019 Japanese Clinical Chemistry and Immunodiagnostic Markets” is a new strategic analysis of majo ...

  • Industries : Drug and Medication
  • Countries : Japan
Future Horizons and Growth Strategies in the Japanese Clinical Chemistry and Immunodiagnostics Market 2015: Supplier Shares and Country Forecasts

Future Horizons and Growth Strategies in the Japanese Clinical Chemistry and Immunodiagnostics Market 2015: Supplier Shares and Country Forecasts

  • $ 4 900
  • Industry report
  • June 2015
  • by Venture Planning Group

Complete report $7,600.  DataPack (test volumes, sales forecasts, supplier shares) $4,900. “Future Horizons and Growth Strategies in the Japanese Clinical Chemistry and Immunodiagnostics Market 2015” ...

  • Industries : Drug and Medication
  • Countries : Japan
Global Insulin Market to 2019 - Market Size, Development, Top 10 Countries, and Forecasts

Global Insulin Market to 2019 - Market Size, Development, Top 10 Countries, and Forecasts

  • $ 5 174
  • Industry report
  • August 2015
  • by Global Research & Data Services Oy

The industry report package Global Insulin Market to 2019 - Market Size, Development, Top 10 Countries, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook ...

  • Industries : Pathology, Drug and Medication, Pharmaceutical
  • Countries : World
Global Penicillin and Streptomycin Market to 2019 - Market Size, Development, Top 10 Countries, and Forecasts

Global Penicillin and Streptomycin Market to 2019 - Market Size, Development, Top 10 Countries, and Forecasts

  • $ 5 174
  • Industry report
  • August 2015
  • by Global Research & Data Services Oy

The industry report package Global Penicillin and Streptomycin Market to 2019 - Market Size, Development, Top 10 Countries, and Forecasts offers the most up-to-date market data on the actual market situation, ...

  • Industries : Drug and Medication
  • Countries : World
Dyslipidemia Drugs Market:  - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023

Dyslipidemia Drugs Market: - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023

  • $ 4 795
  • Industry report
  • August 2015
  • by Transparency Market Research

Dyslipidemia is a chronic metabolic syndrome, characterized by improper level of low density lipoprotein, high density lipoprotein, and triglycerides. This study on the dyslipidemia drugs market involves ...

  • Industries : Drug and Medication, Pathology
  • Countries : World
Antibacterial Drugs Market  - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023

Antibacterial Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023

  • $ 4 795
  • Industry report
  • July 2015
  • by Transparency Market Research

This report on antibacterial drugs market studies the current as well as future prospects of the market globally. The market for antibacterial drugs is segmented on the basis of major classes of drugs ...

  • Industries : Drug and Medication
  • Countries : World
U.S. General Anesthesia Drugs Market by Molecule, route of administration, Supply Chain, Competitive - Analysis Forecast to 2020

U.S. General Anesthesia Drugs Market by Molecule, route of administration, Supply Chain, Competitive - Analysis Forecast to 2020

  • $ 4 650
  • Industry report
  • July 2015
  • by MarketsandMarkets

The report segments the U.S. general anesthesia drugs market on the basis of molecule and route of administration. On the basis of molecules, the market is divided into Propofol, Benzodiazepine, Ketamine ...

  • Industries : Drug and Medication, Pharmaceutical
  • Countries : United States
Biosimilars Market by Product & Application  - Global Forecast to 2020

Biosimilars Market by Product & Application - Global Forecast to 2020

  • $ 4 650
  • Industry report
  • July 2015
  • by MarketsandMarkets

Various factors have contributed to the rise in demand for biopharmaceutical products such as biologics and biosimilars. Some of these factors include the rising pressure to reduce healthcare expenditure, ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : World, Europe
4-(Methylamino)benzoic acid Chemical Report

4-(Methylamino)benzoic acid Chemical Report

  • $ 4 609
  • Industry report
  • August 2015
  • by PureData

4-(Methylamino)benzoic acid Chemical Report This 4-(Methylamino)benzoic acid Chemical World Consumption Reportt provides data on the net consumption of 4-(Methylamino)benzoic acid in each of the countries ...

  • Industries : Advertising and Marketing, Marketing, Marketing
  • Countries : World
Sodium ceftiofur Chemical Report

Sodium ceftiofur Chemical Report

  • $ 4 609
  • Industry report
  • August 2015
  • by PureData

Sodium ceftiofur Chemical Report This Sodium ceftiofur Chemical World Consumption Reportt provides data on the net consumption of Sodium ceftiofur in each of the countries listed. The substance covered ...

  • Industries : Advertising and Marketing, Drug and Medication
  • Countries : World
Ceftiofur hydrochloride Chemical Report

Ceftiofur hydrochloride Chemical Report

  • $ 4 609
  • Industry report
  • August 2015
  • by PureData

Ceftiofur hydrochloride Chemical Report This Ceftiofur hydrochloride Chemical World Consumption Reportt provides data on the net consumption of Ceftiofur hydrochloride in each of the countries listed. ...

  • Industries : Advertising and Marketing, Drug and Medication, Marketing, Marketing
  • Countries : World
Levofloxacin carboxylic acid Chemical Report

Levofloxacin carboxylic acid Chemical Report

  • $ 4 609
  • Industry report
  • August 2015
  • by PureData

Levofloxacin carboxylic acid Chemical Report This Levofloxacin carboxylic acid Chemical World Consumption Reportt provides data on the net consumption of Levofloxacin carboxylic acid in each of the ...

  • Industries : Drug and Medication
  • Countries : World
Mivacurium chloride Chemical Report

Mivacurium chloride Chemical Report

  • $ 4 609
  • Industry report
  • August 2015
  • by PureData

Mivacurium chloride Chemical Report This Mivacurium chloride Chemical World Consumption Reportt provides data on the net consumption of Mivacurium chloride in each of the countries listed. The substance ...

  • Industries : Advertising and Marketing, Drug and Medication, Marketing, Marketing
  • Countries : World
Rufinamide Chemical Report

Rufinamide Chemical Report

  • $ 4 609
  • Industry report
  • August 2015
  • by PureData

Rufinamide Chemical Report This Rufinamide Chemical World Consumption Reportt provides data on the net consumption of Rufinamide in each of the countries listed. The substance covered (Rufinamide) are ...

  • Industries : Advertising and Marketing, Marketing, Marketing
  • Countries : World
Clinafloxacin hydrochloride Chemical Report

Clinafloxacin hydrochloride Chemical Report

  • $ 4 609
  • Industry report
  • August 2015
  • by PureData

Clinafloxacin hydrochloride Chemical Report This Clinafloxacin hydrochloride Chemical World Consumption Reportt provides data on the net consumption of Clinafloxacin hydrochloride in each of the countries ...

  • Industries : Advertising and Marketing, Marketing, Marketing
  • Countries : World
About 22 000 reports

Download Unlimited Documents from Trusted Public Sources

Drug Markets in the US

  • September 2015
    8 pages
  • Drug  

    Pharmacy  

  • United States  

    United Kingdom  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.